Penciclovir: a review of its spectrum of activity, selectivity, and cross-resistance pattern

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Antiviral Chemistry and Chemotherapy

• Publication date

  1993-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1177/095632029300401S01
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• An Overview of the Further Evaluation of Penciclovir against Herpes Simplex Virus and Varicella-Zoster Virus in Cell Culture Highlighting Contrasts with Acyclovir

  1993cited by this paper
• Pharmacokinetics of Famciclovir in Man

  1993cited by this paper
• Famciclovir and Penciclovir. The Mode of Action of Famciclovir Including Its Conversion to Penciclovir

  1993cited by this paper
• Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS

  1993cited by this paper
• In vitro activities of penciclovir and acyclovir against herpes simplex virus types 1 and 2

  1992cited by this paper
• A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance

  1992cited by this paper
• The pathogenicity of drug-resistant variants of herpes simplex virus.

  1992cited by this paper
• Resistance of herpesviruses to antiviral drugs

  1992cited by this paper
• Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS.

  1990cited by this paper
• Herpes Simplex Virus Resistant to Acyclovir: A Study in a Tertiary Care Center

  1990cited by this paper
• Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells

  1989cited by this paper
• Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?

  1989cited by this paper
• Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir]

  1989cited by this paper
• Prodrugs of the selective antiherpesvirus agent 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine (BRL 39123) with improved gastrointestinal absorption properties.

  1989cited by this paper
• Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in animals

  1988cited by this paper
• Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture

  1987cited by this paper
• Critical determinants of antiherpes efficacy of buciclovir and related acyclic guanosine analogs.

  1987cited by this paper
• Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity

  1987cited by this paper
• An Improved Synthesis of the Antiviral Acyclonucleoside 9-(4-Hydroxy-3-hydroxymethylbut-1-yl)guanine.

  1986cited by this paper
• Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir

  1986cited by this paper
• Synthetic, Biochemical and Antiviral Aspects of Selected Acyclonucleosides and Their Derivatives.

  1986cited by this paper
• Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates

  1985cited by this paper
• Antiherpes Simplex Virus Activity of 9-[4-Hydroxy-3-(hydroxymethyl)-1-butyl] guanine

  1984cited by this paper
• Influence of cell culture conditions on the inhibition of herpes simplex virus type 1 replication by acyclovir.

  1982cited by this paper
• Acyclovir treatment of experimental simian varicella infection of monkeys

  1981cited by this paper
• In vitro susceptibility of varicella-zoster virus to acyclovir

  1980cited by this paper

• Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trial

  2025cites this paper
• Reconstructive Methodology in the Synthesis of 2-Aminopurine

  2023cites this paper
• An Insight into Current Treatment Strategies, Their Limitations, and Ongoing Developments in Vaccine Technologies against Herpes Simplex Infections

  2023cites this paper
• An unmodified boron-doped diamond electrode for electroanalytical investigation and sensitive voltammetric quantification of antiviral drug famciclovir in the pharmaceutical formulation and serum samples

  2022cites this paper
• An Overview of Marketed Nucleoside and Nucleotide Analogs

  2022cites this paper
• Acyclovir Resistance in Herpes Simplex Viruses: Prevalence and Therapeutic Alternatives.

  2022cites this paper
• DNA polymerases of herpesviruses and their inhibitors.

  2021cites this paper
• Viral Disease of the Cornea and External Eye

  2021cites this paper
• Antiviral Drugs Against Herpesviruses.

  2021cites this paper
• The Oak Leaf: LSUA’s Journal of Undergraduate Teaching and Research

  2021cites this paper
• Current Antivirals and Novel Botanical Molecules Interfering With Herpes Simplex Virus Infection

  2020cites this paper
• Synthesis and anti-HSV activity of tricyclic penciclovir and hydroxybutylguanine derivatives

  2019influential citation
• Solid-State Characterization and Compatibility Studies of Penciclovir, Lysine Hydrochloride, and Pharmaceutical Excipients

  2019cites this paper
• The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold

  2018cites this paper
• Evaluation of Multitudinous Potentials of Photosynthetic Microalga, Neochloris aquatica RDS02 Derived Silver Nanoparticles

  2018cites this paper
• 4 Point Mutations and Antiviral Drug Resistance

  2018cites this paper
• ANTIVIRAL DRUG REVIEW A GUIDE TO CLINICIANS

  2017influential citation
• Prodrug Approaches to Drug Delivery

  2016cites this paper
• -yl)methyl}guanine (A-5021) in Cell Culture ' -Bis(hydroxymethyl)cycloprop-1 '

  2014cites this paper
• Recent developments in anti-herpesvirus drugs.

  2013cites this paper
• Point Mutations and Antiviral Drug Resistance

  2012cites this paper
• 2-[4,5-Difluoro-2-(2-Fluorobenzoylamino)-Benzoylamino]Benzoic Acid, an Antiviral Compound with Activity against Acyclovir-Resistant Isolates of Herpes Simplex Virus Types 1 and 2

  2012cites this paper
• Equine herpesvirus 4: recent advances using BAC technology.

  2011cites this paper
• Characterization of a thymidine kinase-deficient mutant of equine herpesvirus 4 and in vitro susceptibility of the virus to antiviral agents.

  2010cites this paper
• Antiviral Drugs (Other than Antiretrovirals)

  2010cites this paper
• An update on the management of glandular fever (infectious mononucleosis) and its sequelae caused by Epstein–Barr virus (HHV-4): new and emerging treatment strategies

  2010cites this paper
• Resistance of Herpes Simplex Viruses to Nucleoside Analogues: Mechanisms, Prevalence, and Management

  2010cites this paper
• Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus.

  2010cites this paper
• Inhibitory activity of oxyresveratrol on wild-type and drug-resistant varicella-zoster virus replication in vitro.

  2009cites this paper
• Antiherpesviral DNA Polymerase Inhibitors

  2009cites this paper
• Susceptibility Test Methods: Viruses*

  2009cites this paper
• Penciclovir is a potent inhibitor of feline herpesvirus-1 with susceptibility determined at the level of virus-encoded thymidine kinase.

  2008cites this paper
• Synthesis and Biological Evaluation of Some α-[6-(1′-Carbamoylalkylthio)-1 H-Pyrazolo[3,4-D]Pyrimidin-4-yl]Thioalkylcarboxamide Acyclonucleosides

  2007cites this paper
• Management of recurrent oral herpes simplex infections.

  2007cites this paper
• New antiviral agents

  2006cites this paper
• Management of herpes simplex virus type 2 infection in HIV type 1-infected persons.

  2006cites this paper
• Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management.

  2006cites this paper
• Investigation of antiviral and anticancer nucleoside analog substrate recognition of drosophila melanogaster and herpes virus deoxyribonucleoside kinases

  2006cites this paper
• Famciclovir for the Management of Genital Herpes Simplex in Patients with Inadequate Response to Aciclovir or Valaciclovir

  2005cites this paper
• Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus.

  2005cites this paper
• Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster.

  2004cites this paper
• The antiviral prophylaxis of post-transplant lymphoproliferative disorder

  2004cites this paper
• Penciclovir Cream – Improved Topical Treatment for Herpes simplex Infections

  2004cites this paper
• Emerging therapies for herpes viral infections (types 1 – 8)

  2004cites this paper
• Clinical Manifestations and Treatment Modalities in Herpes Simplex Virus of the Ocular Anterior Segment

  2004cites this paper
• Herpes simplex virus resistance to antiviral drugs.

  2003cites this paper
• Recurrent herpes simplex labialis: selected therapeutic options.

  2003cites this paper
• Herpes Simplex Virus Resistance to Acyclovir and Penciclovir after Two Decades of Antiviral Therapy

  2003cites this paper
• Recurrent Herpes Simplex Labialis: Selected Therapeutic Options (Récurrence de l'herpès labial : options thérapeutiques)

  2003cites this paper
• Susceptibilities of Herpes Simplex Viruses to Penciclovir and Acyclovir in Eight Cell Lines

  2002cites this paper
• Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials.

  2002cites this paper
• Comparison of methods for identifying resistant herpes simplex virus and measuring antiviral susceptibility.

  2002cites this paper
• Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial

  2002cites this paper
• Antiviral agents: Nonantiviral drugs

  2002cites this paper
• Virus population dynamics, fitness variations and the control of viral disease: an update.

  2001cites this paper
• Separation methods for acyclovir and related antiviral compounds.

  2001cites this paper
• Herpes simplex virus antiviral drug resistance--current trends and future prospects.

  2001cites this paper
• Current and potential therapies for the treatment of herpes-virus infections

  2001cites this paper
• Characterization of Herpes Simplex Viruses Selected in Culture for Resistance to Penciclovir or Acyclovir

  2001cites this paper
• Current options for the therapy of chronic hepatitis B infection

  2001cites this paper
• Absence of rapid selection for acyclovir or penciclovir resistance following suboptimal oral prodrug therapy of HSV-infected mice

  2001cites this paper
• 8-[18F]Fluoropenciclovir: an improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET.

  2001cites this paper
• Treatment of chronic woodchuck hepatitis virus infection in the eastern woodchuck (marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans

  2000cites this paper
• Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals

  2000cites this paper
• Pharmacocinétique et pharmacodynamie du valaciclovir et du famciclovir

  2000cites this paper
• Effects of Antiviral Usage on Transmission Dynamics of Herpes Simplex Virus Type 1 and on Antiviral Resistance: Predictions of Mathematical Models

  2000influential citation
• Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo

  2000cites this paper
• Efficacy of Topical Acyclovir Monophosphate, Acyclovir, or Penciclovir in Orofacial HSV-1 Infections of Mice and Genital HSV-2 Infections of Guinea Pigs

  2000cites this paper
• A comparison of topical application of penciclovir 1% cream with acyclovir 3% cream for treatment of genital herpes: a randomized, double-blind, multicentre trial

  2000cites this paper
• Imaging transgene expression with radionuclide imaging technologies.

  2000cites this paper
• Difference in Incidence of Spontaneous Mutations between Herpes Simplex Virus Types 1 and 2

  2000influential citation
• Antiviral chemotherapy for the treatment of hepatitis B virus infections.

  2000cites this paper
• Susceptibility of Clinical Strains of Herpes simplex Virus to Three Nucleoside Analogues

  2000cites this paper
• Herpes zoster: focus on treatment in older adults.

  1999cites this paper
• Human Herpesvirus 8-Encoded Thymidine Kinase and Phosphotransferase Homologues Confer Sensitivity to Ganciclovir

  1999cites this paper
• Emergence of resistance to acyclovir and penciclovir in varicella-zoster virus and genetic analysis of acyclovir-resistant variants.

  1999cites this paper
• Evaluation of anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]- guanine (A-5021) in mice.

  1999cites this paper
• New therapeutic strategies in the treatment of hepatitis B virus infection.

  1999cites this paper
• Antiviral Chemotherapy 5

  1999cites this paper
• Intravenous Penciclovir for Treatment of Herpes Simplex Infections in Immunocompromised Patients: Results of a Multicenter, Acyclovir-Controlled Trial

  1999cites this paper
• Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors.

  1999cites this paper
• Synthesis and evaluation of amino acid esters of 6-deoxypenciclovir as potential prodrugs of penciclovir.

  1999cites this paper
• The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice.

  1999cites this paper
• Famciclovir for the Suppression of Symptomatic and Asymptomatic Herpes Simplex Virus Reactivation in HIV-Infected Persons: A Double-Blind, Placebo-Controlled Trial

  1998cites this paper
• The Novel Immunosuppressive Agent Mycophenolate Mofetil Markedly Potentiates the Antiherpesvirus Activities of Acyclovir, Ganciclovir, and Penciclovir In Vitro and In Vivo

  1998cites this paper
• Famciclovir and Valaciclovir Differ in the Prevention of Herpes Simplex Virus Type 1 Latency in Mice: a Quantitative Study

  1998cites this paper
• Penciclovir and pathogenesis phenotypes of drug-resistant Herpes simplex virus mutants.

  1998cites this paper
• Famciclovir. Discovery and development of a novel antiherpesvirus agent.

  1998cites this paper
• Antiherpesvirus Activities of (1′S,2′R)-9-{[1′,2′-Bis(hydroxymethyl)cycloprop-1′-yl]methyl}guanine (A-5021) in Cell Culture

  1998cites this paper
• Long-Term Therapy with the Guanine Nucleoside Analog Penciclovir Controls Chronic Duck Hepatitis B Virus Infection In Vivo

  1998cites this paper
• Valaciclovir: development, clinical utility and potential.

  1997cites this paper
• ACUTE HERPES ZOSTER AND POSTHERPETIC NEURALGIA

  1997cites this paper
• Effets et risques des traitements antiviraux prolongés : l'exemple de l'hépatite B chronique

  1997cites this paper
• Chapter 31. To Market, To Market - 1996

  1997cites this paper
• Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation.

  1997cites this paper
• REVIEW: Present and future directions in the treatment of chronic hepatitis B infection

  1997cites this paper
• Penciclovir Pharmacokinetics and Distribution to the Brain and Muscle of Rats, Studied by Microdialysis

  1997cites this paper
• WHAT CLINICIANS NEED TO KNOW ABOUT ANTIVIRAL DRUGS AND VIRAL RESISTANCE

  1997cites this paper
• Inhibitory Effect of Penciclovir-Triphosphate on Duck Hepatitis B Virus Reverse Transcription

  1997cites this paper
• Section Review: Anti-infectives: Novel herpes treatments: A review

  1996cites this paper